Developer docs
API playgroundTry for free, no card

Search company profiles

biotrial neuroscience

Full company profile

uuid02mbuhj

Namestring
biotrial neuroscience
Legal namestring
Biotrial
Websiteurl
biotrial.com
Company typeenum
Private
Founded yearint
1989
Descriptiontext

Biotrial was founded in 1989 and is a privately held, full-service contract research organization headquartered in Rennes, France. It serves biotechnology and pharmaceutical sponsors with nonclinical pharmacology and safety studies, Phase I studies in healthy volunteers and specialized populations, patient and oncology trial management, bioanalysis, biometrics, electronic data capture, biostatistics, pharmacovigilance, regulatory affairs, ECG, CNS testing, EEG and polysomnography, medical imaging, and data science.\n\nBiotrial reports 150 Phase I beds in Rennes and 110 in Newark, New Jersey, for 260 beds in total. It also reports hundreds of studies annually, approximately 10,000 bioanalysis samples per month, and experience managing more than 50 patient trials in over 20 countries during the past five years. Its operating stack combines purpose-built clinical facilities and specialist laboratories with Medidata Rave, implemented in 2015, Clincase, SafetyEasy, Watson LIMS, CDISC standards, and OMOP capabilities. Biotrial also describes a proprietary PEPSY cognitive-testing platform, LC-MS/MS systems, central EEG and cardiac-safety services, and AI, NLP, deep-learning, and generative-AI tools used in SAS, R, and Python for pharmacometrics, in-silico trials, and real-world data analysis.\n\nBiotrial generates revenue through customized CRO projects, with pricing determined by study scope, complexity, therapeutic area, duration, and geographic requirements. It reaches sponsors through direct enterprise sales and assigns multidisciplinary project teams that support studies from protocol design through data management, analysis, and regulatory submission. Public pricing, backlog, customer-level revenue, and named customer portfolios are not available.

Short descriptiontext

Biotrial is a private, full-service CRO serving biotechnology and pharmaceutical sponsors with preclinical, Phase I, patient-trial, bioanalytical, biometrics, Core Lab, regulatory, and data-science services across Europe and North America through purpose-built clinical units and specialist facilities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersRennes, France
HQ citystring
Rennes
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract research organization, clinical trial services, preclinical drug development, bioanalytical services, central laboratory services
Industry5 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization (CRO) Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Organization (CRO) Services
TypeProfessional Services
Description

Biotrial generates revenue through comprehensive contract research services spanning non-clinical pharmacology, clinical development (Phase I studies with healthy volunteers and patients), bioanalysis, biometrics, Core Lab services, and data science. Services are provided on a project/contract basis to biotechnology and pharmaceutical sponsors, with pricing based on study scope, complexity, and duration.

biotrial.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Biotrial is a full-service Contract Research Organization (CRO) that provides integrated drug development services spanning non-clinical pharmacology, clinical development (Phase I trials with healthy volunteers and patients), bioanalysis, biometrics, and Core Lab services (EEG, ECG, medical imaging). The company operates purpose-built Phase I clinical pharmacology units in France (150 beds) and the USA (110 beds) and serves biotechnology and pharmaceutical sponsors worldwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Industry-leading turnaround times for bioanalysis including first-to-file studies
+2 more records
Product overview1 text field

Biotrial Neuroscience is a Contract Research Organization (CRO) providing integrated drug development services across the pharmaceutical pipeline. The company operates as a platform of interconnected service divisions: Nonclinical Services delivers preclinical safety and oncology models; Core Lab Services provides specialized CNS, cardiac, and imaging assessments; Clinical Services manages Phase I-IV trials; Data Science Services offers pharmacometric modeling and AI-powered in-silico trials; Bioanalysis Services handles sample analysis and storage; and Biometrics Services manages EDC, biostatistics, and medical writing. These services work together to provide sponsors with end-to-end clinical research capabilities from early discovery through regulatory submission.

Product and service6 records
1Nonclinical Services
CategoryPreclinical / Non-clinical Pharmacology
Description

Comprehensive preclinical testing services including Safety, Efficacy, PK Studies, Model Development, and In Vitro and In Vivo Models for Oncology research, offered to biotechnology and pharmaceutical sponsors.

2Core Lab Services
CategoryCore Laboratory / Cardiac Safety / CNS Imaging
Description

Specialized laboratory services including Central EEG & Polysomnography, CNS Testing, Cardiac Safety & ECG, QT Investigations, and Medical Imaging for clinical trials.

3Clinical Services
CategoryClinical Trial Management (Phase I/Patient)
Description

Full-service clinical trial management including Phase 1 Healthy Volunteers studies, Specialized Phase 1 studies, Oncology Trial Management, Patient Trial Management, Clinical Monitoring, Pharmacovigilance & Medical Monitoring, Pharmaceutical Affairs, and Regulatory Affairs.

4Data Science Services
CategoryData Science / Pharmacometrics / In-Silico Trials
Description

Advanced analytics and modeling services including Pharmacometrics & PK/PD modeling, In-Silico Trials, and Real World Data analysis using AI, NLP, deep learning, and generative AI algorithms.

5Bioanalysis Services
CategoryBioanalysis / LC-MS/MS
Description

Comprehensive bioanalytical services including Non-GLP & Discovery Services, Method Development & Method Transfer, GLP Non-clinical Sample Analysis, Quantitative Bioanalysis using LC-MS MS, and Sample Management & Storage.

6Biometrics Services
CategoryBiometrics / Data Management / Biostatistics
Description

Clinical data management services including Electronic Data Capture (EDC) using Medidata Rave and Clincase platforms, Data Management, Biostatistics, and Medical Writing.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Pareann Biotechnologies
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-01
Description

Biotrial has strengthened its partnership with Pareann Biotechnologies to expand preclinical and clinical capabilities. The collaboration focuses on development of a novel preclinical lung cancer model combining controlled microbiome, humanized immune system, and tumor cells derived from patients (MESHCAP project).

biotrial.com
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Celerion is a closely comparable early-phase clinical CRO specializing in Phase I studies, bioanalytical services, and clinical pharmacology. Both operate dedicated Phase I clinical pharmacology units and emphasize bioanalytical capabilities with similar sponsor profiles.

TypeDirect peer
Description

Altasciences is a mid-sized full-service CRO with strong early-phase clinical and bioanalytical capabilities, including purpose-built Phase I facilities. Directly comparable in service mix, therapeutic focus (CNS, oncology), and target customer base of biotech and pharma sponsors.

TypeDirect peer
Description

Worldwide Clinical Trials is a mid-market CRO with deep CNS, oncology, and cardiometabolic expertise. Comparable to Biotrial in therapeutic area specialization, Phase I/early-phase capabilities, and mid-sized positioning relative to mega-CROs.

TypeDirect peer
Description

Medpace is a mid-to-large CRO with strong Phase I/early-phase capabilities and therapeutic specialization across multiple areas including oncology and CNS. Similar full-service clinical development model targeting biotech and pharma sponsors.

TypeBroad incumbent
Description

ICON is one of the largest global CROs offering end-to-end drug development services including Phase I. Comparable in service breadth and sponsor overlap, but operates at a substantially larger scale across more geographies.

TypeBroad incumbent
Description

Parexel is a large global full-service CRO with comparable Phase I through Phase IV capabilities. Overlaps significantly with Biotrial in CNS, oncology, and cardiovascular therapeutic areas but operates at materially larger scale.

TypeBroad incumbent
Description

Syneos Health is a large global CRO and commercialization provider offering clinical development services including early-phase trials. Comparable in full-service positioning but with a much broader geographic and operational footprint.

TypeBroad incumbent
Description

Eurofins operates a large bioanalytical and central laboratory business serving pharma and biotech sponsors. Overlaps with Biotrial's bioanalysis and central lab offerings through its Pharma Services division, with much broader scale.

TypeBroad incumbent
Description

PPD, now part of Thermo Fisher, is one of the world's largest CROs offering end-to-end clinical development services. Comparable in early-phase to Phase IV capabilities but at vastly larger scale and geographic reach.

TypeBroad incumbent
Description

Charles River operates Discovery & Safety Assessment, Manufacturing, and CDMO services with significant preclinical CRO overlap with Biotrial's Non-clinical Services division. Comparable in pharma/biotech sponsor base but broader in scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

biotrial neuroscience

Contract Research Organization (CRO) Servicesbiotrial.com

Biotrial is a private, full-service CRO serving biotechnology and pharmaceutical sponsors with preclinical, Phase I, patient-trial, bioanalytical, biometrics, Core Lab, regulatory, and data-science services across Europe and North America through purpose-built clinical units and specialist facilities.

What biotrial neuroscience does

Biotrial was founded in 1989 and is a privately held, full-service contract research organization headquartered in Rennes, France. It serves biotechnology and pharmaceutical sponsors with nonclinical pharmacology and safety studies, Phase I studies in healthy volunteers and specialized populations, patient and oncology trial management, bioanalysis, biometrics, electronic data capture, biostatistics, pharmacovigilance, regulatory affairs, ECG, CNS testing, EEG and polysomnography, medical imaging, and data science.\n\nBiotrial reports 150 Phase I beds in Rennes and 110 in Newark, New Jersey, for 260 beds in total. It also reports hundreds of studies annually, approximately 10,000 bioanalysis samples per month, and experience managing more than 50 patient trials in over 20 countries during the past five years. Its operating stack combines purpose-built clinical facilities and specialist laboratories with Medidata Rave, implemented in 2015, Clincase, SafetyEasy, Watson LIMS, CDISC standards, and OMOP capabilities. Biotrial also describes a proprietary PEPSY cognitive-testing platform, LC-MS/MS systems, central EEG and cardiac-safety services, and AI, NLP, deep-learning, and generative-AI tools used in SAS, R, and Python for pharmacometrics, in-silico trials, and real-world data analysis.\n\nBiotrial generates revenue through customized CRO projects, with pricing determined by study scope, complexity, therapeutic area, duration, and geographic requirements. It reaches sponsors through direct enterprise sales and assigns multidisciplinary project teams that support studies from protocol design through data management, analysis, and regulatory submission. Public pricing, backlog, customer-level revenue, and named customer portfolios are not available.

biotrial neuroscience firmographics

Firmographics
Name
biotrial neuroscience
Legal name
Biotrial
Website
https://biotrial.com
Company type
Private
Founded year
1989
Operating status
Operating
Headcount range
251–500 employees
Short description
Biotrial is a private, full-service CRO serving biotechnology and pharmaceutical sponsors with preclinical, Phase I, patient-trial, bioanalytical, biometrics, Core Lab, regulatory, and data-science services across Europe and North America through purpose-built clinical units and specialist facilities.
Ownership category
akta.pro rank

biotrial neuroscience industry classification

Industry
Product category
Contract Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Keywords

  • Contract research organization
  • Clinical trial services
  • Preclinical drug development
  • Bioanalytical services
  • Central laboratory services

Where biotrial neuroscience is headquartered

Location

Headquarters

HQ city
Rennes
HQ country
France
HQ region
Europe

Offices4 records

Markets served

biotrial neuroscience business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Contract Research Organization (CRO) Services: Biotrial generates revenue through comprehensive contract research services spanning non-clinical pharmacology, clinical development (Phase I studies with healthy volunteers and patients), bioanalysis, biometrics, Core Lab services, and data science. Services are provided on a project/contract basis to biotechnology and pharmaceutical sponsors, with pricing based on study scope, complexity, and duration.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

biotrial neuroscience product offering

Product offering

Core offering

Biotrial is a full-service Contract Research Organization (CRO) that provides integrated drug development services spanning non-clinical pharmacology, clinical development (Phase I trials with healthy volunteers and patients), bioanalysis, biometrics, and Core Lab services (EEG, ECG, medical imaging). The company operates purpose-built Phase I clinical pharmacology units in France (150 beds) and the USA (110 beds) and serves biotechnology and pharmaceutical sponsors worldwide.

Product overview

Biotrial Neuroscience is a Contract Research Organization (CRO) providing integrated drug development services across the pharmaceutical pipeline. The company operates as a platform of interconnected service divisions: Nonclinical Services delivers preclinical safety and oncology models; Core Lab Services provides specialized CNS, cardiac, and imaging assessments; Clinical Services manages Phase I-IV trials; Data Science Services offers pharmacometric modeling and AI-powered in-silico trials; Bioanalysis Services handles sample analysis and storage; and Biometrics Services manages EDC, biostatistics, and medical writing. These services work together to provide sponsors with end-to-end clinical research capabilities from early discovery through regulatory submission.

Differentiator

Problem solved

Functional benefit

Products and services

  • Nonclinical Services Comprehensive preclinical testing services including Safety, Efficacy, PK Studies, Model Development, and In Vitro and In Vivo Models for Oncology research, offered to biotechnology and pharmaceutical sponsors.
  • Core Lab Services Specialized laboratory services including Central EEG & Polysomnography, CNS Testing, Cardiac Safety & ECG, QT Investigations, and Medical Imaging for clinical trials.
  • Clinical Services Full-service clinical trial management including Phase 1 Healthy Volunteers studies, Specialized Phase 1 studies, Oncology Trial Management, Patient Trial Management, Clinical Monitoring, Pharmacovigilance & Medical Monitoring, Pharmaceutical Affairs, and Regulatory Affairs.
  • Data Science Services Advanced analytics and modeling services including Pharmacometrics & PK/PD modeling, In-Silico Trials, and Real World Data analysis using AI, NLP, deep learning, and generative AI algorithms.
  • Bioanalysis Services Comprehensive bioanalytical services including Non-GLP & Discovery Services, Method Development & Method Transfer, GLP Non-clinical Sample Analysis, Quantitative Bioanalysis using LC-MS MS, and Sample Management & Storage.
  • Biometrics Services Clinical data management services including Electronic Data Capture (EDC) using Medidata Rave and Clincase platforms, Data Management, Biostatistics, and Medical Writing.

Quantifiable outcome

  • Industry-leading turnaround times for bioanalysis including first-to-file studies
  • +2 more outcomes

Companies that use biotrial neuroscience

Customer profile

Segments3 records

Ideal customer profiles2 records

biotrial neuroscience technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability5 records

Feature6 records

biotrial neuroscience partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Pareann BiotechnologiescoreStrategic or Co-development Partner · 1 March 2026Biotrial has strengthened its partnership with Pareann Biotechnologies to expand preclinical and clinical capabilities. The collaboration focuses on development of a novel preclinical lung cancer model combining controlled microbiome, humanized immune system, and tumor cells derived from patients (MESHCAP project).

Scale indicators5 records

Recent moves3 records

Expansion highlights4 records

biotrial neuroscience competitors and assessment

Company assessment

Direct peers

  • Celerion: Celerion is a closely comparable early-phase clinical CRO specializing in Phase I studies, bioanalytical services, and clinical pharmacology. Both operate dedicated Phase I clinical pharmacology units and emphasize bioanalytical capabilities with similar sponsor profiles.
  • Altasciences: Altasciences is a mid-sized full-service CRO with strong early-phase clinical and bioanalytical capabilities, including purpose-built Phase I facilities. Directly comparable in service mix, therapeutic focus (CNS, oncology), and target customer base of biotech and pharma sponsors.
  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-market CRO with deep CNS, oncology, and cardiometabolic expertise. Comparable to Biotrial in therapeutic area specialization, Phase I/early-phase capabilities, and mid-sized positioning relative to mega-CROs.
  • Medpace: Medpace is a mid-to-large CRO with strong Phase I/early-phase capabilities and therapeutic specialization across multiple areas including oncology and CNS. Similar full-service clinical development model targeting biotech and pharma sponsors.

Broad incumbents

  • ICON plc: ICON is one of the largest global CROs offering end-to-end drug development services including Phase I. Comparable in service breadth and sponsor overlap, but operates at a substantially larger scale across more geographies.
  • Parexel International: Parexel is a large global full-service CRO with comparable Phase I through Phase IV capabilities. Overlaps significantly with Biotrial in CNS, oncology, and cardiovascular therapeutic areas but operates at materially larger scale.
  • Syneos Health: Syneos Health is a large global CRO and commercialization provider offering clinical development services including early-phase trials. Comparable in full-service positioning but with a much broader geographic and operational footprint.
  • Eurofins Scientific: Eurofins operates a large bioanalytical and central laboratory business serving pharma and biotech sponsors. Overlaps with Biotrial's bioanalysis and central lab offerings through its Pharma Services division, with much broader scale.
  • PPD (Thermo Fisher Scientific): PPD, now part of Thermo Fisher, is one of the world's largest CROs offering end-to-end clinical development services. Comparable in early-phase to Phase IV capabilities but at vastly larger scale and geographic reach.
  • Charles River Laboratories: Charles River operates Discovery & Safety Assessment, Manufacturing, and CDMO services with significant preclinical CRO overlap with Biotrial's Non-clinical Services division. Comparable in pharma/biotech sponsor base but broader in scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

biotrial neuroscience social profiles

Digital presence

biotrial neuroscience compliance and trust

Trust signal

Compliance3 records

biotrial neuroscience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

biotrial neuroscience leadership team

Management profile

Number of profiles

Profiles11 records

biotrial neuroscience funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

biotrial neuroscience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about biotrial neuroscience

What does biotrial neuroscience do?

Biotrial is a full-service Contract Research Organization (CRO) that provides integrated drug development services spanning non-clinical pharmacology, clinical development (Phase I trials with healthy volunteers and patients), bioanalysis, biometrics, and Core Lab services (EEG, ECG, medical imaging). The company operates purpose-built Phase I clinical pharmacology units in France (150 beds) and the USA (110 beds) and serves biotechnology and pharmaceutical sponsors worldwide.

Is biotrial neuroscience a public or private company?

biotrial neuroscience is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was biotrial neuroscience founded?

biotrial neuroscience was founded in 1989. It employs 251 to 500 people.

Where is biotrial neuroscience based?

biotrial neuroscience is headquartered in Rennes, France, in the Europe region.

How does biotrial neuroscience make money?

One revenue line is on record: contract Research Organization (CRO) Services.

Who are biotrial neuroscience's main competitors?

Direct peers on record are Celerion, Altasciences, Worldwide Clinical Trials and Medpace. Broad incumbents are ICON plc, Parexel International, Syneos Health, Eurofins Scientific, PPD (Thermo Fisher Scientific) and Charles River Laboratories.

Does biotrial neuroscience have an API?

No public API is recorded for biotrial neuroscience.

What industry is biotrial neuroscience in?

biotrial neuroscience's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialBiotrial COO Nicolas Fauchoux Honored As Top 50 COONicolas Fauchoux, COO of Biotrial, was named to the top 50 COOs at the OnCon Icon Awards. He led Biotrial's U.S. expansion, establishing a Clinical Pharmacology Unit in Newark, New Jersey. The company continues to operate facilities in France, the U.S., England, and Canada.Business InsiderAuthorities are wrapping up their investigation of a deadly drug trial that left one dead and several others in hospitalThe French Health Ministry found Biotrial at fault for a drug trial that left one volunteer dead and five others hospitalized with brain disorders. The trial involved 90 people, and the company will still be allowed to carry out drug trials. A full report will not be published until late March.PR Newswire APACBionomics Begins Phase 1b Study With Anxiety Drug Bnc210Bionomics initiated a Phase 1b clinical trial of BNC210, an anxiety drug, in healthy volunteers. The trial, conducted by Biotrial International in France, will test safety, tolerability, and pharmacokinetics in over 50 male volunteers. A Phase 2a study in anxiety patients is planned for Q1 2015 in the UK.GlobeNewswireArno Therapeutics Initiates Pharmacokinetic Study for Onapristone Following Regulatory AcceptanceArno Therapeutics initiated a pharmacokinetic study of onapristone after the French health authority approved its IMPD. The study will recruit 12 healthy volunteers to examine food effects on absorption, with Biotrial as CRO. The company plans to start Phase 1 in PR-positive tumors later this year.